Trust issues

Is there a crisis of trust?

https://ourworldindata.org/coronavirus

John’s free textbooks

Download my two comprehensive but free educational text books or make a donation to the campbellteaching project using this link: http://159.69.48.3Russia

https://www.youtube.com/watch?v=ijgNJpUes4Y

https://www.dailymail.co.uk/news/article-10084049/Video-showing-Putin-coughing-meeting-emerges-forced-deny-having-Covid-19.html

Infections, + 29,409

Deaths, + 973 = 217,000

Delta variant

Vaccine hesitancy

First dose, 33%

Rolled out before trials

Problem is not that bad

Government had won the war on covid-19

Mr. Putin pulls out of G20 meeting due to ‘diary clash’

Two doses of Sputnik V

ITU, 8,000 patients

Patients becoming critical in 3 to 4 days

Vaccination passports cost 70 euros

Widespread public misconceptions

Hygiene rules hardly followed

Limited restrictions

Limited mask wearing

Official information not believed

Indian summer just now

Moscow may well cope

New infectious disease hospital

Regions, hospitals already full

Molnupiravir, Merck, awaiting EMU

US government at $700 (£515) per course

Analysts at Harvard School of Public Health and King’s College Hospital in London have found it costs just $17.74 (£13) to produce.

Despite this, Merck and Ridgeback could earn $7 billion in profits by the end of the year.

https://news.sky.com/story/covid-news-uk-latest-live-experts-discover-why-people-get-covid-toes-as-wales-introduces-vaccine-passports-12425651

https://www.fiercepharma.com/pharma/merck-molnupiravir-blockbuster-covid-19-pandemic-endemic-oral-antivirals-market

That’s about $700 per course. Merck said it expects to make 10 million courses of the drug by the end of 2021, meaning $7 billion in revenue




BBC Media Action


£1,569,000 in 2019 - 2020

https://www.bbc.co.uk/mediaaction/about/funding

https://www.bbc.co.uk/mediaaction/about/annual-reports

https://www.bbc.co.uk/mediaaction/where-we-work

We support the independent media essential to democracy and development.

We inform, connect and inspire change in our audiences, providing trusted information, stories and ideas that generate discussion and bridge divides.

helping to save lives and improve health, protect livelihoods, challenge inequality and build more peaceful and democratic societies.

Coronavirus: lessons learned to date

https://committees.parliament.uk/publications/7496/documents/78687/default/

in 2020 the UK did significantly worse in terms of covid deaths than many countries—especially compared to those in East Asia

The UK’s pandemic planning was too narrowly and inflexibly based on a flu model which failed to learn the lessons from SARS, MERS and Ebola.

In the first three months the strategy reflected official scientific advice to the Government which was accepted and implemented.

When the Government moved from the ‘contain’ stage to the ‘delay’ stage,

that approach involved trying to manage the spread of covid through the population rather than to stop it spreading altogether.

This amounted in practice to accepting that herd immunity by infection was the inevitable outcome,

The UK, along with many other countries in Europe and North America made a serious early error in adopting this fatalistic approach

and not considering a more emphatic and rigorous approach to stopping the spread of the virus as adopted by many East and South East Asian countries.

The fact that the UK approach reflected a consensus between official scientific advisers and the Government indicates a degree of groupthink

that was present at the time which meant we were not as open to approaches being taken elsewhere as we should have been.